Tryp Therapeuatics (TRYPF) Coverage Report

________________________________________________________________ EQUITY RESEARCH HEALTHCARE Biotechnology Matthew L. Kaplan (212) 891-5247 mkaplan@ladenburg.com Biotechnology Ahu Demir, Ph.D. (561) 620-2102 ademir@ladenburg.com Biopharmaceuticals Michael Higgins (212) 409-2074 mhiggins@ladenburg.com Healthcare & Medical Technologies Jeffrey S. Cohen (561) 620-2049 jcohen@ladenburg.com FINANCIAL INSTITUTIONS Financial Services – Business Development Co. & Specialty Finance Mickey M. Schleien, CFA (305) 572-4131 mschleien@ladenburg.com Financial Services – Business Development Co. & Specialty Finance Christopher Nolan, CFA (212) 409-2068 cnolan@ladenburg.com Financial Services – Equity REITs John J. Massocca (212) 409-2543 jmassocca@ladenburg.com SPECIALTY CONSUMER/CANNABIS Specialty Consumer/Cannabis Glenn G. Mattson (212) 409-2073 gmattson@ladenburg.com TECHNOLOGY Internet & Software Services Jon R. Hickman (510) 918-4045 jhickman@ladenburg.com Software and Services Glenn G. Mattson (212) 409-2073 gmattson@ladenburg.com ADDITIONAL CONTACTS Kenneth Brush, Head of Trading (212) 409-2011 kbrush@ladenburg.com Eric Novotny (212) 409-2011 enovotny@ladenburg.com 640 Fifth Avenue 4 th Floor New York, NY 10019 (212) 409-2000